Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer The article by Grills ...
University of Utah medical physicist Dennis D. Leavitt, Ph.D., who is nationally recognized for his contributions to cancer research, education, and clinical care through radiation oncology, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback